Cargando…
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica
OBJECTIVE: Severe damage to the blood-brain barrier (BBB) allows anti-aquaporin 4 (AQP4) antibodies to access the astrocytic endfeet in neuromyelitis optica (NMO). In the current study, we identified the pathogenic cytokines/chemokines that are responsible for the BBB malfunction induced by NMO sera...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374747/ https://www.ncbi.nlm.nih.gov/pubmed/25811465 http://dx.doi.org/10.1371/journal.pone.0122000 |
_version_ | 1782363537273782272 |
---|---|
author | Shimizu, Fumitaka Nishihara, Hideaki Sano, Yasuteru Takeshita, Yukio Takahashi, Shiori Maeda, Toshihiko Takahashi, Toshiyuki Abe, Masaaki Koga, Michiaki Kanda, Takashi |
author_facet | Shimizu, Fumitaka Nishihara, Hideaki Sano, Yasuteru Takeshita, Yukio Takahashi, Shiori Maeda, Toshihiko Takahashi, Toshiyuki Abe, Masaaki Koga, Michiaki Kanda, Takashi |
author_sort | Shimizu, Fumitaka |
collection | PubMed |
description | OBJECTIVE: Severe damage to the blood-brain barrier (BBB) allows anti-aquaporin 4 (AQP4) antibodies to access the astrocytic endfeet in neuromyelitis optica (NMO). In the current study, we identified the pathogenic cytokines/chemokines that are responsible for the BBB malfunction induced by NMO sera. METHODS: We measured the levels of 27 cytokines/chemokines in human brain microvascular endothelial cells (BMECs) after exposure to sera obtained from patients with the acute and stable phases of anti-AQP4 antibody-positive NMO spectrum disorder (NMOSD), multiple sclerosis (MS) patients and healthy controls (HC) using a multiplexed fluorescent bead-based immunoassay system. RESULTS: The induced protein (IP)-10 level in the cells was markedly increased following exposure to acute phase NMOSD sera. Other cytokines/chemokines including interleukin (IL)-6 and monocyte chemotactic protein (MCP)-1 were also significantly increased in the acute NMOSD group compared to both the MS and HC groups. The up-regulation of the IP-10 levels in the cells after exposure to the acute-phase NMOSD sera was also observed using another specified ELISA, and this effect was significantly decreased during the remission phase in the individual NMOSD patients. Furthermore, the increase in the level of IP-10 after exposure to the sera was significantly correlated with the cerebrospinal fluid/serum albumin ratio. CONCLUSIONS: Sera from the acute phase of NMO markedly increased the autocrine secretion of IP-10 by BMECs. The over-production of IP-10 in BMECs may play an important role in the pathogenesis of NMO and may therefore help to mediate the trafficking of T cells expressing its receptor across the BBB. |
format | Online Article Text |
id | pubmed-4374747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43747472015-04-04 Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica Shimizu, Fumitaka Nishihara, Hideaki Sano, Yasuteru Takeshita, Yukio Takahashi, Shiori Maeda, Toshihiko Takahashi, Toshiyuki Abe, Masaaki Koga, Michiaki Kanda, Takashi PLoS One Research Article OBJECTIVE: Severe damage to the blood-brain barrier (BBB) allows anti-aquaporin 4 (AQP4) antibodies to access the astrocytic endfeet in neuromyelitis optica (NMO). In the current study, we identified the pathogenic cytokines/chemokines that are responsible for the BBB malfunction induced by NMO sera. METHODS: We measured the levels of 27 cytokines/chemokines in human brain microvascular endothelial cells (BMECs) after exposure to sera obtained from patients with the acute and stable phases of anti-AQP4 antibody-positive NMO spectrum disorder (NMOSD), multiple sclerosis (MS) patients and healthy controls (HC) using a multiplexed fluorescent bead-based immunoassay system. RESULTS: The induced protein (IP)-10 level in the cells was markedly increased following exposure to acute phase NMOSD sera. Other cytokines/chemokines including interleukin (IL)-6 and monocyte chemotactic protein (MCP)-1 were also significantly increased in the acute NMOSD group compared to both the MS and HC groups. The up-regulation of the IP-10 levels in the cells after exposure to the acute-phase NMOSD sera was also observed using another specified ELISA, and this effect was significantly decreased during the remission phase in the individual NMOSD patients. Furthermore, the increase in the level of IP-10 after exposure to the sera was significantly correlated with the cerebrospinal fluid/serum albumin ratio. CONCLUSIONS: Sera from the acute phase of NMO markedly increased the autocrine secretion of IP-10 by BMECs. The over-production of IP-10 in BMECs may play an important role in the pathogenesis of NMO and may therefore help to mediate the trafficking of T cells expressing its receptor across the BBB. Public Library of Science 2015-03-26 /pmc/articles/PMC4374747/ /pubmed/25811465 http://dx.doi.org/10.1371/journal.pone.0122000 Text en © 2015 Shimizu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Shimizu, Fumitaka Nishihara, Hideaki Sano, Yasuteru Takeshita, Yukio Takahashi, Shiori Maeda, Toshihiko Takahashi, Toshiyuki Abe, Masaaki Koga, Michiaki Kanda, Takashi Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica |
title | Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica |
title_full | Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica |
title_fullStr | Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica |
title_full_unstemmed | Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica |
title_short | Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica |
title_sort | markedly increased ip-10 production by blood-brain barrier in neuromyelitis optica |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374747/ https://www.ncbi.nlm.nih.gov/pubmed/25811465 http://dx.doi.org/10.1371/journal.pone.0122000 |
work_keys_str_mv | AT shimizufumitaka markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica AT nishiharahideaki markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica AT sanoyasuteru markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica AT takeshitayukio markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica AT takahashishiori markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica AT maedatoshihiko markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica AT takahashitoshiyuki markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica AT abemasaaki markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica AT kogamichiaki markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica AT kandatakashi markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica |